Bruno Tocque
16Patents
7h-index
9Co-inventors
55Inventor score
Filing activity: Oct 19, 1994 → Nov 19, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6372432B1 | Methods and composition for the detection of pathologic events | Chemistry; Metallurgy | 23 | Expired |
| US5886150A | Peptides capable of binding to the GAP protein SH3 domain, nucleotide sequences coding therefor, and preparation and use thereof | Chemistry; Metallurgy | 21 | Expired |
| US5637456A | Rapid test for determining the amount of functionally inactive gene in a gene therapy vector preparation | Chemistry; Metallurgy | 10 | Expired |
| US6251590A | Differential Qualitative screening | Chemistry; Metallurgy | 10 | Expired |
| US5831048A | Grb3-3 cDNA and polypeptides | Human Necessities | 9 | Expired |
| US6159947A | Anti-RAS intracellular binding proteins and use thereof | Human Necessities | 8 | Expired |
| US6881571B1 | Qualitative differential screening | Chemistry; Metallurgy | 7 | Expired |
| US6028245A | Transgenic animals overexpressing MDM2 | Human Necessities | 5 | Expired |
| US5656595A | Peptides having GDP exchange factor activity, nucleic acid sequences coding for these peptides, preparation and use | Human Necessities | 5 | Expired |
| US6262032A | Method of destroying hyperproliferative cells by combined p53 and taxoid treatment | Human Necessities | 3 | Expired |
| US6544948B1 | &Dgr;P62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer | Chemistry; Metallurgy | 3 | Expired |
| US6509153B1 | Genetic markers of toxicity preparation and uses | Chemistry; Metallurgy | 2 | Expired |
| US6180362A | Peptides which inhibit ras protein activity, their preparation and use | Human Necessities | 1 | Expired |
| US7884082B2 | Combined therapeutical treatment of hyperproliferative diseases | Human Necessities | 0 | Expired |
| US8003375B2 | Qualitative differential screening | Chemistry; Metallurgy | 0 | Active |
| USRE37952E1 | Grb3-3 cDNA and polypeptides | General | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.